Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Exactly 30 years ago, I was pondering a graph of primate group sizes plotted against the size of their brains: the larger the brain, the larger the group size. I was curious to know what group size this relationship might predict for humans.

The number my calculations gave was 150. Since this seemed low, I hurried off to the library to look for data on natural human group sizes. Hunter-gatherers live in multilevel societies, with groupings of individuals forming a hierarchically layered structure – families within bands, bands within communities, communities within tribes.

The community level of organisation turned out to be almost exactly 150. Thus was born the “social brain hypothesis” and “Dunbar’s number”, the former referring to the relationship between group size and brain size in primates and the latter referring to the natural group size of about 150 for humans.

Dunbar’s number has attracted a great deal of attention over the years. For example, it has been used in the design of social media platforms, as well as being the basis of “secret handshake” online security algorithms and bot-detection software.

Read the full article on The Conversation website, written by Emeritus Professor Robin Dunbar, Department of Experimental Psychology

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Professor Susan Jebb appointed as Chair of the Food Standards Agency

Susan Jebb, Professor of Diet and Population Health in Oxford University’s Nuffield Department of Primary Care Health Sciences, has been appointed as the new Chair of the Food Standards Agency.